iRhythm launches Zio long-term continuous monitoring service in Japan

iRhythm (IRTC) Technologies announced the commercial launch in Japan of its Zio long-term continuous ECG monitoring system, commercially introduced in this market as the Zio ECG Recording and Analysis System. “The system provides up to 14 days of continuous, uninterrupted ECG monitoring and leverages a deep-learned artificial intelligence algorithm approved by Japan’s Pharmaceuticals and Medical Devices Agency – and represents a significant advancement over other ambulatory cardiac monitoring options in Japan, including commonly used wired Holter monitors, which capture only 24 to 48 hours of data and other patch-based services that monitor only up to 7 days.”